Skip to main content
SpringerLink
Log in

Ethical Issues in Neurografting of Human Embryonic Cells

  • Published:
Theoretical Medicine and Bioethics Aims and scope Submit manuscript

Abstract

During the last decade neurotransplantation has developed into a technique with the possible potential to repair damaged or degenerating human brain. Effective neurotransplantation has so far been based on the use of fetal brain tissue derived from aborted embryos or fetuses. The ethical issues related to this new therapeutic approach therefore not only concern the possible adverse side effects for a neural graft-receiving patient, but also the relationship between the requirements for fetal tissue and the decision-making process for induced abortion. Although for decades human embryos and fetuses have been the subject of biomedical studies, and, in principle, their use has therefore not been seen as ethically objectionable, the above points made it necessary to reconsider the moral issues. The present paper points out several of these issues, both from the donor and acceptor (patient) point of view. The conclusion is that under a series of restrictions intended to prevent the use of grafts from encouraging induced abortions and to maintain high standards of respect for life and human dignity, neurotransplantation using embryonic or fetal brain tissue parts cannot be rejected on moral grounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Backlund E-O, Granber P-O, Hamberger B, Sedvall G, Seiger A, Olson L. Transplantation of adrenal medullary tissue to striatum in Parkinsonism. In Björklund A. Stenevi U, eds. Neural Grafting in the Mammalian CNS. Fernström Foundation Series. Amsterdam: Elsevier, 1985, pp. 551–556.

    Google Scholar 

  2. Peschanski M, Cesaro P, Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995; 68: 273–285.

    Google Scholar 

  3. CAPIT-HD committee: Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K, Lindvall O, MacMillan J, Roos R. Core assessment programme for intracerebral transplantation in Huntington's disease (CAPIT-HD). Movement Disorders 1996; 11: 143–150.

    Google Scholar 

  4. Madrazo I, Franco-Bourland RE, Castregon H, Cuevas C, Ostrosky-Solis F, Aguilera M, Magallon E, Guizar-Sahagun G, Grijalva E. Fetal striatal brain homografting for Huntington's disease. 5th Int. Symp. on Neural Transplantation. Châtenay-Malabry, 1994 France, P200.

  5. Koller WC, ed. Handbook of Parkinson's Disease. New York: Dekker, 1987.

    Google Scholar 

  6. Hitchcock E. Neural implants and recovery of function: human work. Recovery for Brain Damage. In Rose FD, Johnson DA, eds. New York: Plenum Press, 1992, pp. 67–78.

    Google Scholar 

  7. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD, Björklund A. Grafts of fetal dopamine neurons survive and improve motor function on Parkinson's disease. Science 1990; 247: 574–577.

    Google Scholar 

  8. López-Lozano JJ, Bravo G, Brera B, Uria J, De Argello J, Salmean J, Insausti J. CPH Neural Transplantation Group. Can an analogy be drawn between the clinical evaluation of Parkinson's patients who undergo autoimplantation of adrenal medulla and those of fetal ventral mesencephalon transplant recipients? Restor Neurol 1991; 4: 87–98.

    Google Scholar 

  9. Madrazo I, Franco-Bourland M, Aguilera M, Ostrosky-Solis F, Cuevas C, Castregon H, Velazquez D, Grijalva E, Guizar-Sahagun G, Magallon E, Madrazo M. Fetal ventral mesencephalon brain homotransplantation in Parkinson's disease; the Mexican experience. Restor Neurol 1991; 4: 123–130.

    Google Scholar 

  10. Molina H, Quiñones R, Alvarez L, Galarraga J, Piedra J, Suárez C, Rachid M, García JC, Perry TL, Santana A, Carmenate H, Macías R, Torres O, Rojas MJ, Córdova F, Muñoz JL. Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: the Cuban experience. Restor Neurol 1991; 4: 99–110.

    Google Scholar 

  11. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O, Langston JW. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 1992; 327: 1556–1563.

    Google Scholar 

  12. Peschanski M, Defer G, N'yuen JP, Ricolfi F, Monfort JC, Remy P, Geny C, Samson Y, Hantraye P, Jeny R, Gaston A, Kéravel Y, Degos JD, Cesaro P. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994; 117: 487–499.

    Google Scholar 

  13. Falkner F, Tanner JM (eds.) Human growth 1, Principles and Prenatal Growth.London: Baillière Tindall, 1978.

  14. O'Rahilly R, Müller F. Developmental Stages in Human Embryos. Washington: Carnegie Institution of Washington, 1987.

    Google Scholar 

  15. Gareth Jones D. Fetal neural transplantation: placing the ethical debate within the context of society's use of human material. Bioethics 1991; 5: 23–43.

    Google Scholar 

  16. American Medical Association. Medical applications of fetal tissue transplantation. JAMA 1990; 263: 565–570.

    Google Scholar 

  17. McCullagh PM. The Foetus as Transplant Donor. Scientific, Social and Ethical Perspectives. Chichester: Wiley, 1987.

    Google Scholar 

  18. Greely HT, Hamm T, Johnson R, Price CR, Weingarten R, Raffin T. The Stanford University Medical Center Committee on Ethics. The ethical use of human fetal tissue in medicine. N Engl J Med 1989; 320: 1093–1096.

    Google Scholar 

  19. Nolan K. The use of embryo or fetus in transplantation: what there is to lose. Transplant Proc 1990; 22: 1028–1029.

    Google Scholar 

  20. MacDonald AS. Foetal neoroendocrine tissue transplantation for Parkinson's disease: an institutional review board faces the ethical dilemma. Transplant Proc 1990; 22: 1030–1032.

    Google Scholar 

  21. Warren MA. On the moral and legal status of abortion. In Wasserstrom R, ed. Today's Moral Problems. New York: McMillan, 1975, pp. 120–136.

    Google Scholar 

  22. Bopp J, Burtchaell JT. Report of the Human Fetal Tissue Research Panel, Vol 1. Washington: US Government Printing Office, 1988: 45–71.

    Google Scholar 

  23. Burtchaell JT. Case study: university policy on experimental use of aboreted fetal tissue. IRB: A Review of Human Subject Research 1988; 10: 7–11.

    Google Scholar 

  24. Robertson JA. Rights, symbolism and public policy in fetal tissue transplants. Hastings Center Report 6, 1988.

  25. Robertson JA. The ethical acceptability of fetal tissue transplants. Transplant Proc 1990; 22: 1025–1027.

    Google Scholar 

  26. BMA guidelines on the use of fetal tissue. Lancet 1988; 1: 1119.

    Google Scholar 

  27. Committee of the Netherlands Health Council. Advice on Donation and Use of Fetuses, Fetal Tissue and other Remains of Abortion for Scientific Purposes (Kuitert report). The Hague: Health Council of the Netherlands, no. 19, 1984.

    Google Scholar 

  28. Department of Health and Social Security. The Use of Fetuses and Fetal Material for Research, Report of the Advisory Group (Peel report). London: Her Majesty's Stationary Office, 1972.

    Google Scholar 

  29. Dutch Committee on Ethical Aspects of Medical Research. Annual Report 1991 and 1992. The Hague: Health Council of the Netherlands, Publication K93/01, 1993.

    Google Scholar 

  30. National Consultative Ethics Committee for Life Sciences and Health (CNESVS). Recommendation on the Use of Embryo Tissue as well as Tissue of Dead Foetuses for Therapeutic, Diagnostic and Scientific Purposes. Paris: Le Comité, 1984.

    Google Scholar 

  31. National Consultative Ethics Committee for Life Sciences and Health (CNESVS). Statement on Intracerebral Graft of Mesencephalic Tissue of Human Embryo Origin in Patients with Parkinsonism for Therapeutic Experimentation. Paris: Le Comité, 1990.

    Google Scholar 

  32. Parliamentary Assembly of the Council of Europe. On the use of human embryos and foetuses for diagnostic, therapeutic, scientific, industrial and commercial purposes. Recommendations 1046 and 1100. Strasbourg: Council of Europe, 1986.

    Google Scholar 

  33. Working Group on Human Embryos and Research (HER). Second Report, Brussels: EC Directorate General XII, Science Research and Development, 1994.

    Google Scholar 

  34. Boer GJ. Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and reseach. J Neurol 1994; 242: 1–13.

    Google Scholar 

  35. Beauchamp TL, Childress JE. Principles of Biomedical Ethics. New York: Oxford University Press, 1989.

    Google Scholar 

  36. Brundin P, Nilsson PG, Strecker RE, Lindvall O, Astedt B, Björklund A. Behavioral effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 1986; 65: 235–240.

    Google Scholar 

  37. CPMP Working Party on Efficacy of Medicinal Products. EEC note for guidance: Good clinical practice for trials on medicinal products in the European community. Pharmacol Toxicol 1990; 67: 361–372.

    Google Scholar 

  38. Hoffer BJ, Olson L. Ethical issues in brain-cell transplantation. TINS 1991; 14: 384–388.

    Google Scholar 

  39. Missa J-N. Brain physical manipulation and individual personality. In: Proceedings Euroworkshop ‘Ethical Aspects in Brain Research', Rome, 1995.

  40. Sladek JR, Shoulson I. Neural transplantation: a call for patience rather than patients. Science 1988; 240: 1386–1388.

    Google Scholar 

  41. Bankiewicz K, Mandel RJ, Sofroniew MV. Trophism, transplantation, and animal models of Parkinson's disease. Exp Neurol 1993; 124: 140–149.

    Google Scholar 

  42. Spenger C, Studer L, Evtouchenko L, Egli M, Burgunder JM, Markwalder R, Seiler RW. Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon. J Neurosci Meth 1994; 54: 63–73.

    Google Scholar 

  43. Shults CW. Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors. Parkinson's Disease 1992; 10: 567–593.

    Google Scholar 

  44. Takayama H, Ray J, Raymon HK, Baird A, Hogg J Fisher, Gage FH. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Medicine 1995; 1: 53–58.

    Google Scholar 

  45. Cohen-Hagenauer O. Oversight of regulation of gene therapy in Europe. A current statement including reference to US-regulation. Human Gene Therapy 1994; November issue: 1–10.

  46. Björklund A. Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Current Opinion in Neurobiology 1992; 2: 683–689.

    Google Scholar 

  47. Boer GJ, Griffioen HA, Duindam H, Van der Woude TP, Rietveld WJ. Light-Dark-induced effects on behavioral rhythms in suprachiasmatic nucleus-lesioned rats irrespective of the presence of functional suprachiasmatic nucleus brain implants. J Interdiscipl Cycle Res 1993; 24: 118–136.

    Google Scholar 

  48. Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990; 247: 975–978.

    Google Scholar 

  49. Arendash GW, Gorski RA. Enhancement of sexual behavior in female rats by neonatal transplantation of brain tissue from males. Science 1982; 217: 1276–1278.

    Google Scholar 

  50. Gibson MJ, Krieger DT, Charlton HM, Zimmerman EA, Silverman A-J, Perlow MJ. Mating and pregnancy can occur in genetically hypogonadal mice with preoptic area brain grafts. Science 1984; 225: 949–951.

    Google Scholar 

  51. Cefalo RC, Berghmans RLP, Hall SP.The bioethics of human fetal tissue research and therapy: moral decision making of professionals. Am J Obstet Gynecol 1994; 170: 12–19.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Graduate School Neurosciences Amsterdam, Netherlands Institute for Brain Research, Meibergdreef 33, 1105 AZ, Amsterdam ZO, The Netherlands E-mail

    G. J. Boer

Authors
  1. G. J. Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boer, G.J. Ethical Issues in Neurografting of Human Embryonic Cells. Theor Med Bioeth 20, 461–475 (1999). https://doi.org/10.1023/A:1009985223158

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009985223158

Keywords

Search

Navigation